Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;14(1):1-9.
doi: 10.1016/j.ccep.2021.10.001. Epub 2022 Jan 22.

Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients

Michele Magnocavallo  1 , Giampaolo Vetta  2 , Domenico G Della Rocca  3 , Carola Gianni  4 , Sanghamitra Mohanty  4 , Mohamed Bassiouny  4 , Luca Di Lullo  5 , Armando Del Prete  6 , Donatello Cirone  7 , Carlo Lavalle  2 , Cristina Chimenti  2 , Amin Al-Ahmad  4 , J David Burkhardt  4 , G Joseph Gallinghouse  4 , Javier E Sanchez  4 , Rodney P Horton  4 , Luigi Di Biase  8 , Andrea Natale  9
Affiliations
Review

Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients

Michele Magnocavallo et al. Card Electrophysiol Clin. 2022 Mar.

Abstract

COVID-19 mainly affects the respiratory system but has been correlated with cardiovascular manifestations such as myocarditis, heart failure, acute coronary syndromes, and arrhythmias. Cardiac arrhythmias are the second most frequent complication affecting about 30% of patients. Several mechanisms may lead to an increased risk of cardiac arrhythmias during COVID-19 infection, ranging from direct myocardial damage to extracardiac involvement. The aim of this review is to describe the role of COVID-19 in the pathogenesis of cardiac arrhythmias and provide a comprehensive guidance for their monitoring and management.

Keywords: Atrial fibrillation; Atrial flutter; COVID-19; Catheter ablation; Rhythm control; Supraventricular arrhythmias.

PubMed Disclaimer

Conflict of interest statement

Disclosure Dr J.D. Burkhardt is a consultant for Biosense Webster and Stereotaxis. Dr L. Di Biase is a consultant for Biosense Webster, Boston Scientific, Stereotaxis, and St. Jude Medical; and has received speaker honoraria from Medtronic, Atricure, EPiEP, and Biotronik. Dr A. Natale has received speaker honoraria from Boston Scientific, Biosense Webster, St. Jude Medical, Biotronik, and Medtronic; and is a consultant for Biosense Webster, St. Jude Medical, and Janssen. All other authors have reported that they have no relationships relevant to the contents of this article to disclose.

Figures

Fig. 1
Fig. 1
Potential mechanisms of arrhythmia and COVID-19. IL, interleukin; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Fig. 2
Fig. 2
Acute treatment of AF and AFL in COVID-19 patients. AF, atrial fibrillation; AFL, atrial flutter.
See this image and copyright information in PMC

References

    1. Lipsitch M., Swerdlow D.L., Finelli L. Defining the epidemiology of covid-19 — studies needed. N Engl J Med. 2020;382:1194–1196. - PubMed
    1. Jee Y. WHO international health regulations emergency committee for the COVID-19 outbreak. Epidemiol Health. 2020;42:e2020013. - PMC - PubMed
    1. Vetta F. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a Vicious circle. J Cardiol Cardiovasc Res. 2020 doi: 10.37191/Mapsci-JCCR-1(1)-010. - DOI
    1. Shi S., Qin M., Shen B., et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802. - PMC - PubMed
    1. Della Rocca D.G., Magnocavallo M., Lavalle C., et al. Evidence of systemic endothelial injury and Microthrombosis in hospitalized COVID-19 patients at different Stages of the disease. J Thromb Thrombolysis. 2020 doi: 10.1007/s11239-020-02330-1. - DOI - PMC - PubMed